Abeona Therapeutics (ABEO) Revenue (Gross): 2021-2025
Historic Revenue (Gross) for Abeona Therapeutics (ABEO) over the last 4 years, with Sep 2025 value amounting to $1.7 million.
- Abeona Therapeutics' Revenue (Gross) rose 40.62% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.0 million, marking a year-over-year increase of 26.88%. This contributed to the annual value of $4.2 million for FY2024, which is 100.57% up from last year.
- Per Abeona Therapeutics' latest filing, its Revenue (Gross) stood at $1.7 million for Q3 2025, which was up 62.80% from $1.0 million recorded in Q2 2025.
- In the past 5 years, Abeona Therapeutics' Revenue (Gross) registered a high of $1.7 million during Q3 2025, and its lowest value of $5,000 during Q4 2021.
- Moreover, its 3-year median value for Revenue (Gross) was $1.0 million (2024), whereas its average is $942,909.
- Per our database at Business Quant, Abeona Therapeutics' Revenue (Gross) soared by 6,460.00% in 2022 and then dropped by 13.77% in 2025.
- Over the past 5 years, Abeona Therapeutics' Revenue (Gross) (Quarterly) stood at $5,000 in 2021, then surged by 6,460.00% to $328,000 in 2022, then skyrocketed by 126.52% to $743,000 in 2023, then spiked by 37.69% to $1.0 million in 2024, then surged by 40.62% to $1.7 million in 2025.
- Its last three reported values are $1.7 million in Q3 2025, $1.0 million for Q2 2025, and $1.3 million during Q1 2025.